Celecoxib and Meningitis - a phase IV clinical study of FDA data

Summary:

Meningitis is reported as a side effect among people who take Celecoxib (celecoxib), especially for people who are female, 60+ old, also take Methotrexate, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Meningitis when taking Celecoxib. It is created by eHealthMe based on reports of 37,974 people who have side effects when taking Celecoxib from the FDA, and is updated regularly.

What is Celecoxib?

Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 38,217 Celecoxib users. Check the latest studies of Celecoxib.

What is Meningitis?

Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges) is found to be associated with 651 drugs and 880 conditions by eHealthMe. Check the latest studies of Meningitis.

On Jul, 10, 2026

37,974 people reported to have side effects when taking Celecoxib.
Among them, 21 people (0.06%) have Meningitis.

Among these 21 people:

What is the gender of people who have Meningitis when taking Celecoxib? *

female: 65 %
male: 35 %

What is the age of people who have Meningitis when taking Celecoxib? *

What are other drugs people take besides Celecoxib? *

What are other side effects people have besides Meningitis? *

Herpes Zoster: 4 people, 19.05%
Headache (pain in head): 4 people, 19.05%
Hypoacusis (loss of hearing): 3 people, 14.29%
Weakness: 3 people, 14.29%
Encephalitis (inflammation of the brain): 3 people, 14.29%
High Blood Pressure: 3 people, 14.29%
Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 2 people, 9.52%
Ear Congestion: 2 people, 9.52%
Dyspnea (difficult or laboured breathing): 2 people, 9.52%
Cardiac Failure Congestive: 2 people, 9.52%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 10 people, 47.62%
Osteoporosis (bones weak and more likely to break): 6 people, 28.57%
Vasculitis (inflammation of a blood vessel or blood vessels): 3 people, 14.29%
Intertrigo (inflammation (rash) of the body folds (adjacent areas of skin)): 3 people, 14.29%
Athlete's Foot (a fungal infection affecting the skin between the toes): 3 people, 14.29%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 14.29%
Cellulitis (infection under the skin): 3 people, 14.29%
Forearm Fracture (fracture in between wrist to elbow): 3 people, 14.29%
Hyperlipidaemia (presence of excess lipids in the blood): 3 people, 14.29%
Allergic Rhinitis: 3 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Celecoxib and have Meningitis?

- Check whether Meningitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celecoxib:

Celecoxib (38,217 reports)

Meningitis treatments and more:

Meningitis (9,443 reports)

Browse all side effects of Celecoxib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Meningitis:

Meningitis (651 drugs)

Browse all the conditions that are associated with Meningitis:

Meningitis (880 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celecoxib) and Celecoxib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.